Prognosis of single tooth implants following alveolar ridge preservation with two recombinant human bone morphogenetic protein-2 delivery systems
| العنوان: | Prognosis of single tooth implants following alveolar ridge preservation with two recombinant human bone morphogenetic protein-2 delivery systems |
|---|---|
| المؤلفون: | Young-Kyun Kim, Il-hyung Kim, Pil-Young Yun, Hyeong-Jin Baek |
| المصدر: | BMC Oral Health, Vol 21, Iss 1, Pp 1-6 (2021) BMC Oral Health |
| بيانات النشر: | Springer Science and Business Media LLC, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Survival rate, Bone Morphogenetic Protein 2, Dentistry, Human bone, Bone morphogenetic protein, 03 medical and health sciences, Dental Implants, Single-Tooth, 0302 clinical medicine, Transforming Growth Factor beta, Republic of Korea, Escherichia coli, Alveolar ridge, Humans, Medicine, Tooth Socket, General Dentistry, Retrospective Studies, rhBMP-2 protein, Bone substitutes, Alveolar bone loss, business.industry, Research, Alveolar process, Dental implants, RK1-715, Alveolar Ridge Augmentation, 030206 dentistry, Prognosis, Implant stability quotient, Recombinant Proteins, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Tooth Extraction, Oral and maxillofacial surgery, Implant, business, Follow-Up Studies |
| الوصف: | Background We previously reported similar efficacies of alveolar ridge preservation (ARP) on single extraction socket with two different E. coli derived recombinant human bone morphogenetic protein-2 (rhBMP-2) delivery systems (Cowell BMP, Cowell medi Co, Busan, Korea; β-tricalcium phosphate and hydroxyapatite particle & O-BMP, Osstem Implant Co, Busan, Korea; absorbable collagen sponge). After the trial, we completed implant therapy and observed over an average of 3 years. This follow-up study was performed retrospectively to compare result of implant treatment at the preserved alveolar ridge site. Methods Patients who underwent extraction of single tooth and received ARP with one of two rhBMP-2 delivery systems from October 2015 to October 2016 were enrolled. Twenty-eight patients (Group 1: Cowell BMP 14; Group 2: O-BMP 14) who underwent implant therapy and prosthetic treatment were included in study. Stability and marginal bone loss (MBL) of each implant were collected from medical charts and radiographs, and analyzed. The survival and success rates of implants were calculated. Results The primary implant stability represented by implant stability quotient (ISQ) for Groups 1 and 2 was 69.71 and 72.86, respectively. The secondary implant stability for Groups 1 and 2 was 78.86 and 81.64, respectively. Primary and secondary stabilities were not statistically different (P = 0.316 and 0.185, respectively). MBL at the latest follow-up was 0.014 mm in Group 1 over 33.76 ± 14.31 months and 0.021 mm in Group 2 over 40.20 ± 9.64 months, with no significant difference (P = 0.670). In addition, the success rate of implants was 100% (14/14) in Group 1 and 92.9% (13/14) in Group 2, with survival rate of 100% (14/14) in Group 1 and 92.9% (13/14) in Group 2. Conclusions We confirmed good prognosis in both groups as a result of implant therapy after ARP with each of two rhBMP-2 carriers. |
| تدمد: | 1472-6831 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad182a8f0dda25ca12510739165fa5e https://doi.org/10.1186/s12903-021-01565-5 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....cad182a8f0dda25ca12510739165fa5e |
| قاعدة البيانات: | OpenAIRE |
Find this article in full text from Springer Verlag. | تدمد: | 14726831 |
|---|